FDA Brief

Company record

Unichem Pharmaceuticals USA Inc.

0 FDA warning letters since 2023 and 3 recalls in the last 12 months.

Get an email the day FDA posts anything new about Unichem Pharmaceuticals USA Inc..

Recalls

ReportedClassFirmProduct and reason
May 13 Class III Unichem Pharmaceuticals USA Inc.
Drug
busPIRone Hydrochloride Tablets, USP, 5 mg, 500-count bottle, Rx Only, Manufactured by Unichem Laboratories LTD., Ind, Area, Meerut Road, Ghazibad - 201 003, India Manufactured for: Unichem Pharmaceuticals (USA), Inc. Ea…
Subpotent drug
Feb 18 Class III Unichem Pharmaceuticals USA Inc.
Drug
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories…
Tablets/Capsules Imprinted with Wrong ID
Feb 11 Class II Unichem Pharmaceuticals USA Inc.
Drug
Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIS LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India, Manufactured for: …
cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.